Editorial Materials
|
| BRAFmutant hematopoietic malignancies |
|
https://doi.org/10.18632/oncotarget.2448
|
| 7980-7981 |
Editorial
|
| The reverse Warburg effect in osteosarcoma |
|
https://doi.org/10.18632/oncotarget.2352
|
| 7982-7983 |
|
| Oncogene addiction: resetting the safety switch |
|
https://doi.org/10.18632/oncotarget.2474
|
| 7986-7987 |
Reviews
|
| Screening for E3Ubiquitin ligase inhibitors: challenges and opportunities |
|
https://doi.org/10.18632/oncotarget.2431
|
| 7988-8013 |
|
| The IGF signalling pathway in Wilms tumours A report from the ENCCA Renal Tumours Biologydriven drug development workshop |
|
https://doi.org/10.18632/oncotarget.2485
|
| 8014-8026 |
|
| Correlation of long noncoding RNA expression with metastasis drug resistance and clinical outcome in cancer |
|
https://doi.org/10.18632/oncotarget.2469
|
| 8027-8038 |
|
| Regulatory roles of LINE1encoded reverse transcriptase in cancer onset and progression |
|
https://doi.org/10.18632/oncotarget.2504
|
| 8039-8051 |
Research Perspectives
|
| CUSP9* treatment protocol for recurrent glioblastoma: aprepitant artesunate auranofin captopril celecoxib disulfiram itraconazole ritonavir sertraline augmenting continuous low dose temozolomide |
|
https://doi.org/10.18632/oncotarget.2408
|
| 8052-8082 |
Priority Research Papers
|
| Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas |
|
https://doi.org/10.18632/oncotarget.2342
|
| 8083-8092 |
|
| Anticancer potency of tasquinimod is enhanced via albuminbinding facilitating increased uptake in the tumor microenvironment |
|
https://doi.org/10.18632/oncotarget.2378
|
| 8093-8106 |
|
| TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity |
|
https://doi.org/10.18632/oncotarget.2440
|
| 8107-8122 |
Clinical Research Papers
|
| Identification of a DNA methylation signature to predict diseasefree survival in locally advanced rectal cancer |
|
https://doi.org/10.18632/oncotarget.2347
|
| 8123-8135 |
|
| A first in man phase I trial of the oral immunomodulator indoximod combined with docetaxel in patients with metastatic solid tumors |
|
https://doi.org/10.18632/oncotarget.2357
|
| 8136-8146 |
|
| Coexpression of MET and CD47 is a novel prognosticator for survival of luminaltype breast cancer patients |
|
https://doi.org/10.18632/oncotarget.2385
|
| 8147-8160 |
|
| A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors |
|
https://doi.org/10.18632/oncotarget.2415
|
| 8161-8172 |
Research Papers
|
| A screen for transcription factor targets of glycogen synthase kinase3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2303
|
| 8173-8187 |
|
| Wogonin induces cell cycle arrest and erythroid differentiation in imatinibresistant K562 cells and primary CML cells |
|
https://doi.org/10.18632/oncotarget.2340
|
| 8188-8201 |
|
| Tissuespecific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers |
|
https://doi.org/10.18632/oncotarget.1159
|
| 8202-8210 |
|
| Targeting CD13 aminopeptidaseN in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells |
|
https://doi.org/10.18632/oncotarget.1788
|
| 8211-8222 |
|
| Population distribution and ancestry of the cancer protective MDM2 SNP285 rs117039649 |
|
https://doi.org/10.18632/oncotarget.1910
|
| 8223-8234 |
|
| Activation of EGFR HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice |
|
https://doi.org/10.18632/oncotarget.1632
|
| 8235-8251 |
|
| Neurotensin NTS and its receptor NTSR1 causes EGFR HER2 and HER3 overexpression and their autocrine/paracrine activation in lung tumors confirming responsiveness to erlotinib |
|
https://doi.org/10.18632/oncotarget.1633
|
| 8252-8269 |
|
| Oncogenic RASinduced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved |
|
https://doi.org/10.18632/oncotarget.2013
|
| 8270-8283 |
|
| Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease |
|
https://doi.org/10.18632/oncotarget.2058
|
| 8284-8305 |
|
| Chemical inhibition of acetylCoA carboxylase suppresses selfrenewal growth of cancer stem cells |
|
https://doi.org/10.18632/oncotarget.2059
|
| 8306-8316 |
|
| Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression |
|
https://doi.org/10.18632/oncotarget.2135
|
| 8317-8329 |
|
| Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NFκB signaling pathway |
|
https://doi.org/10.18632/oncotarget.2212
|
| 8330-8340 |
|
| HMGA1 pseudogenes as candidate protooncogenic competitive endogenous RNAs |
|
https://doi.org/10.18632/oncotarget.2202
|
| 8341-8354 |
|
| ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature |
|
https://doi.org/10.18632/oncotarget.2247
|
| 8355-8366 |
|
| Oncogenetriggered suppression of DNA repair leads to DNA instability in cancer |
|
https://doi.org/10.18632/oncotarget.2259
|
| 8367-8378 |
|
| Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulinlike growth factor1 receptorindependent mechanism |
|
https://doi.org/10.18632/oncotarget.2292
|
| 8379-8392 |
|
| TALENmediated Nanog disruption results in less invasiveness more chemosensitivity and reversal of EMT in Hela cells |
|
https://doi.org/10.18632/oncotarget.2298
|
| 8393-8401 |
|
| Therapeutic effect of a TM4SF5specific monoclonal antibody against colon cancer in a mouse model |
|
https://doi.org/10.18632/oncotarget.2311
|
| 8402-8415 |
|
| Inhibition of STAT3 signaling targets both tumorinitiating and differentiated cell populations in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2314
|
| 8416-8428 |
|
| Interferonstimulated gene 15 ISG15 is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2316
|
| 8429-8441 |
|
| Regulatory effects of a Mnk2eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells |
|
https://doi.org/10.18632/oncotarget.2319
|
| 8442-8451 |
|
| Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory ComplexI activity via Bcl2 family proteins |
|
https://doi.org/10.18632/oncotarget.2320
|
| 8452-8465 |
|
| PIWIL2 induces cMyc expression by interacting with NME2 and regulates cMycmediated tumor cell proliferation |
|
https://doi.org/10.18632/oncotarget.2327
|
| 8466-8477 |
|
| The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via NMyc downstreamregulated gene 2 NDRG2/gp130/STAT3 pathway |
|
https://doi.org/10.18632/oncotarget.2328
|
| 8478-8491 |
|
| Spinophilin expression determines cellular growth cancer stemness and 5flourouracil resistance in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.2329
|
| 8492-8502 |
|
| The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets |
|
https://doi.org/10.18632/oncotarget.2330
|
| 8503-8514 |
|
| Efficient lytic induction of kaposi’s sarcomaassociated herpesvirus KSHV by the anthracyclines |
|
https://doi.org/10.18632/oncotarget.2335
|
| 8515-8527 |
|
| Inhibition of lung tumor growth by targeting EGFR/VEGFRAkt/NFκB pathways with novel theanine derivatives |
|
https://doi.org/10.18632/oncotarget.2336
|
| 8528-8543 |
|
| Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors |
|
https://doi.org/10.18632/oncotarget.2337
|
| 8544-8557 |
|
| Loss of the obscurinRhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells |
|
https://doi.org/10.18632/oncotarget.2338
|
| 8558-8568 |
|
| ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2322
|
| 8569-8582 |
|
| EpsteinBarr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.2323
|
| 8583-8601 |
|
| Interfering with the interaction between ErbB1 nucleolin and Ras as a potential treatment for glioblastoma |
|
https://doi.org/10.18632/oncotarget.2343
|
| 8602-8613 |
|
| Selective targeting of liver cancer with the endothelial marker CD146 |
|
https://doi.org/10.18632/oncotarget.2345
|
| 8614-8624 |
|
| Integrated analysis of long noncoding RNAs and mRNAs reveals their potential roles in the pathogenesis of uterine leiomyomas |
|
https://doi.org/10.18632/oncotarget.2349
|
| 8625-8636 |
|
| Selective JAK2/ABL dual inhibition therapy effectively eliminates TKIinsensitive CML stem/progenitor cells |
|
https://doi.org/10.18632/oncotarget.2353
|
| 8637-8650 |
|
| Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease |
|
https://doi.org/10.18632/oncotarget.2354
|
| 8651-8664 |
|
| Induced cancer stemlike cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell |
|
https://doi.org/10.18632/oncotarget.2356
|
| 8665-8680 |
|
| Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer |
|
https://doi.org/10.18632/oncotarget.2365
|
| 8681-8689 |
|
| Intracellular and extracellular domains of protein tyrosine phosphatase PTPRZB differentially regulate glioma cell growth and motility |
|
https://doi.org/10.18632/oncotarget.2366
|
| 8690-8702 |
|
| Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors |
|
https://doi.org/10.18632/oncotarget.2367
|
| 8703-8715 |
|
| IL6stimulated CD11b+ CD14+ HLADR− myeloidderived suppressor cells are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus |
|
https://doi.org/10.18632/oncotarget.2368
|
| 8716-8728 |
|
| Selective methioninaseinduced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity |
|
https://doi.org/10.18632/oncotarget.2369
|
| 8729-8736 |
|
| Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALKmutated neuroblastoma |
|
https://doi.org/10.18632/oncotarget.2372
|
| 8737-8749 |
|
| Using heterogeneity of the patientderived xenograft model to identify the chemoresistant population in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.2373
|
| 8750-8764 |
|
| Interleukin32α downregulates the activity of the Bcell CLL/lymphoma 6 protein by inhibiting protein kinase Cεdependent SUMO2 modification |
|
https://doi.org/10.18632/oncotarget.2364
|
| 8765-8777 |
|
| p21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT and ERKdependent activation of NFκB pathway |
|
https://doi.org/10.18632/oncotarget.2398
|
| 8778-8789 |
|
| IsomiR expression profiles in human lymphoblastoid cell lines exhibit population and gender dependencies |
|
https://doi.org/10.18632/oncotarget.2405
|
| 8790-8802 |
|
| POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in Head and Neck cancer |
|
https://doi.org/10.18632/oncotarget.2492
|
| 8803-8815 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
